In conclusion, our ZIKV NS3 protease PA model and anchors provides valuable understanding of viral protease mechanisms and facilitates the discovery of previr drugs for repurposing in anti-ZIKV treatments for accelerating therapeutic intervention of ZIKV infections. This evidence concerns the gene KRAS and Zika virus infectious disease.